tiprankstipranks
pc:ele6z

Electra Therapeutics

https://electra-therapeutics.com/
A clinical stage biotechnology company pioneering therapies against novel targets for diseases in immunology and cancer. The company’s lead product candidate, ELA026, is a first-in-class monoclonal antibody that targets signal regulatory proteins (SIRP) on immune cells to selectively deplete pathological myeloid cells and T lymphocytes.

Leadership & Board

Key Executives
Chief Executive OfficerAdam Rosenthal
President and Chief Operating OfficerLori Lyons-Williams
Chief Financial OfficerDavid Allison
Chief Scientific OfficerKatherine Bowdish
Founder and ChairmanJohn Hood
Current Number of Employees38
Current LinkedIn Followers2,566

Latest Estimated Valuation

Estimated Valuation
Estimated Valuation
Total Amount Raised$366M
Total Amount Raised$366M
Total Funding Rounds2
Total Funding Rounds2
Latest Funding Amount$183M
Latest Funding Amount$183M
Latest Funding RoundGrowth Round
Latest Funding RoundGrowth Round
Post-Money Valuation
Post-Money Valuation

Employee Trend

Electra Therapeutics had 38 employees as of April 6, 2026. The number of employees increased by 1 (2.70%) week-over-week.
38Latest Employee Count
1(2.70%)Week-Over-Week Change
Employee Trend serves as a data-driven indicator of company growth and expansion. The measurement reflects how a company’s workforce size changes over time.

Social Trend

Electra Therapeutics had 2,566 followers as of April 6, 2026. The number of followers increased by 19 (0.75%) week-over-week.
2,566Latest Followers Count
19(0.75%)Week-Over-Week Change
LinkedIn Follower Trend serves as a data-driven indicator of market interest and company visibility. The measurement reflects how a company’s LinkedIn follower count changes over time.

Funding Round

Funding Date
Funding Round
Amount Raised
Post-Money Valuation
Oct 23, 2025
Growth Round
$183.00M
Oct 22, 2025
Series C
$183.00M

Investors

Investor Name
Funding Round

Related News and Analysis